Lipocine Stock Shares Outstanding
| LPCN Stock | USD 3.54 0.04 1.14% |
Lipocine fundamentals help investors to digest information that contributes to Lipocine's financial success or failures. It also enables traders to predict the movement of Lipocine Stock. The fundamental analysis module provides a way to measure Lipocine's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Lipocine stock.
As of the 23rd of March 2025, Common Stock Shares Outstanding is likely to grow to about 5.7 M. Lipocine | Shares Outstanding |
Lipocine Company Shares Outstanding Analysis
Lipocine's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Lipocine Shares Outstanding | 5.35 M |
Most of Lipocine's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Lipocine is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Lipocine Shares Outstanding Driver Correlations
Understanding the fundamental principles of building solid financial models for Lipocine is extremely important. It helps to project a fair market value of Lipocine Stock properly, considering its historical fundamentals such as Shares Outstanding. Since Lipocine's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Lipocine's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Lipocine's interrelated accounts and indicators.
Click cells to compare fundamentals
Lipocine Shares Outstanding Historical Pattern
Today, most investors in Lipocine Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Lipocine's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's shares outstanding growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Lipocine shares outstanding as a starting point in their analysis.
Lipocine Shares Outstanding |
| Timeline |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Lipocine Common Stock Shares Outstanding
Common Stock Shares Outstanding |
|
Based on the latest financial disclosure, Lipocine has 5.35 M of shares currently outstending. This is 97.04% lower than that of the Pharmaceuticals sector and 94.99% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 99.06% higher than that of the company.
Lipocine Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Lipocine's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Lipocine could also be used in its relative valuation, which is a method of valuing Lipocine by comparing valuation metrics of similar companies.Lipocine is currently under evaluation in shares outstanding category among its peers.
Lipocine Current Valuation Drivers
We derive many important indicators used in calculating different scores of Lipocine from analyzing Lipocine's financial statements. These drivers represent accounts that assess Lipocine's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Lipocine's important valuation drivers and their relationship over time.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Market Cap | 75.0M | 55.6M | 33.8M | 14.7M | 26.1M | 24.8M | |
| Enterprise Value | 61.4M | 55.0M | 30.7M | 9.9M | 19.8M | 18.9M |
Lipocine ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Lipocine's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Lipocine's managers, analysts, and investors.Environmental | Governance | Social |
Lipocine Fundamentals
| Return On Equity | 4.0E-4 | ||||
| Return On Asset | -0.0317 | ||||
| Profit Margin | 0.0008 % | ||||
| Operating Margin | 0.44 % | ||||
| Current Valuation | (2.69 M) | ||||
| Shares Outstanding | 5.35 M | ||||
| Shares Owned By Insiders | 2.90 % | ||||
| Shares Owned By Institutions | 9.15 % | ||||
| Number Of Shares Shorted | 74.79 K | ||||
| Price To Earning | 15.80 X | ||||
| Price To Book | 0.90 X | ||||
| Price To Sales | 1.69 X | ||||
| Revenue | 11.2 M | ||||
| Gross Profit | 11.2 M | ||||
| EBITDA | (1.11 M) | ||||
| Net Income | 8.35 K | ||||
| Cash And Equivalents | 37.4 M | ||||
| Cash Per Share | 0.42 X | ||||
| Total Debt | 1.51 M | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 22.23 X | ||||
| Book Value Per Share | 3.93 X | ||||
| Cash Flow From Operations | (1.22 M) | ||||
| Short Ratio | 2.57 X | ||||
| Target Price | 6.75 | ||||
| Number Of Employees | 16 | ||||
| Beta | 1.42 | ||||
| Market Capitalization | 18.94 M | ||||
| Total Asset | 22.51 M | ||||
| Retained Earnings | (199.77 M) | ||||
| Working Capital | 20.81 M | ||||
| Current Asset | 29.41 M | ||||
| Current Liabilities | 1.57 M | ||||
| Net Asset | 22.51 M |
About Lipocine Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Lipocine's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Lipocine using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Lipocine based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
When determining whether Lipocine offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Lipocine's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Lipocine Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Lipocine Stock: Check out Lipocine Piotroski F Score and Lipocine Altman Z Score analysis. To learn how to invest in Lipocine Stock, please use our How to Invest in Lipocine guide.You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lipocine. If investors know Lipocine will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lipocine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Lipocine is measured differently than its book value, which is the value of Lipocine that is recorded on the company's balance sheet. Investors also form their own opinion of Lipocine's value that differs from its market value or its book value, called intrinsic value, which is Lipocine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lipocine's market value can be influenced by many factors that don't directly affect Lipocine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lipocine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Lipocine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lipocine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.